Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence

BACKGROUND: Clozapine is the only medication licenced for patients with psychosis that is resistant to conventional antipsychotic treatment. However, despite its effectiveness, it remains widely underutilised. One contributory factor for this may be clinicians’ lack of confidence around the manageme...

Descripción completa

Detalles Bibliográficos
Autores principales: Oloyede, Ebenezer, Mantell, Bethany, Williams, Julie, Lai, Serena, Jauhar, Sameer, Taylor, David, MacCabe, James H., Harland, Robert, McGuire, Philip, Blackman, Graham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806412/
https://www.ncbi.nlm.nih.gov/pubmed/36601352
http://dx.doi.org/10.1177/20451253221141222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806412/
https://www.ncbi.nlm.nih.gov/pubmed/36601352
http://dx.doi.org/10.1177/20451253221141222

Ejemplares similares